Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study Academic Article uri icon

authors

  • Kosiborod, M
  • Lam, CSP
  • Kohsaka, S
  • Kim, DJ
  • Karasik, A
  • Shaw, J
  • Tangri, N
  • Goh, SY
  • Thuresson, M
  • Chen, H
  • Surmont, F
  • Hammar, N
  • Fenici, P
  • Kosiborod, M
  • Cavender, MA
  • Fu, AZ
  • Wilding, JP
  • Khunti, K
  • Norhammar, A
  • Birkeland, K
  • Jørgensen, ME
  • Holl, RW
  • Lam, CS
  • Gulseth, HL
  • Carstensen, B
  • Bollow, E
  • Franch-Nadal, J
  • García Rodríguez, LA
  • Tangri, N
  • Kohsaka, S
  • Kim, DJ
  • Shaw, J
  • Arnold, S
  • Goh, SY
  • Bodegård, J
  • Chen, H
  • Nahrebne, K
  • Blak, BT
  • Wittbrodt, ET
  • Saathoff, M
  • Noguchi, Y
  • Tan, D
  • Williams, M
  • Lee, HW
  • Greenbloom, M
  • Kaidanovich-Beilin, O
  • Yeo, KK
  • Bee, YM
  • Khoo, J
  • Koong, A
  • Lau, YH
  • Gao, F
  • Tan, WB
  • Kadir, HA
  • Ha, KH
  • Lee, J
  • Chodick, G
  • Melzer Cohen, C
  • Whitlock, R
  • Cea Soriano, L
  • Fernándex Cantero, O
  • Riehle, E
  • Ilomaki, J
  • Magliano, D

publication date

  • June 12, 2018